Breath Diagnostics
Prospect
About Breath Diagnostics
Breath Diagnostics's mission is to globally implement breath analysis technology to provide early detection for cancers and reduce patient exposure to costly, high risk medical procedures. They have developed a patented technology that will determine if a patient has lung cancer by analyzing a patient’s breath with parts per billion accuracy, allowing very early detection. They have studied over 700 patients. This has the potential to save a significant number of lives and save the healthcare industry significant dollars.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $250.0K
- Last round: Series Unknown (Mar 2020)
- Website: breathdiagnostics.com
Industries & Categories
Clinical Trials, Health Care, Medical Device, Wellness
Social Profiles
Canonical: https://fsome.com/organization/breath-diagnostics-202066 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.